1452 related articles for article (PubMed ID: 31003032)
21. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells.
Cioca DP; Deak E; Cioca F; Paunescu V
J Immunother; 2006; 29(1):41-52. PubMed ID: 16365599
[TBL] [Abstract][Full Text] [Related]
23. Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets.
Balkhi MY; Latchumanan VK; Singh B; Sharma P; Natarajan K
J Leukoc Biol; 2004 May; 75(5):874-83. PubMed ID: 14966193
[TBL] [Abstract][Full Text] [Related]
24. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.
Hensley SE; Giles-Davis W; McCoy KC; Weninger W; Ertl HC
J Immunol; 2005 Nov; 175(9):6032-41. PubMed ID: 16237098
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
27. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
28. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
29. MyD88 and interferon-alpha/beta are differentially required for dendritic cell maturation but dispensable for development of protective memory against Listeria.
Tam MA; Wick MJ
Immunology; 2009 Nov; 128(3):429-38. PubMed ID: 20067542
[TBL] [Abstract][Full Text] [Related]
30. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
31. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
[TBL] [Abstract][Full Text] [Related]
32. Tubulation of endosomal structures in human dendritic cells by Toll-like receptor ligation and lymphocyte contact accompanies antigen cross-presentation.
Compeer EB; Flinsenberg TW; Boon L; Hoekstra ME; Boes M
J Biol Chem; 2014 Jan; 289(1):520-8. PubMed ID: 24235148
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells.
León B; Martínez del Hoyo G; Parrillas V; Vargas HH; Sánchez-Mateos P; Longo N; López-Bravo M; Ardavín C
Blood; 2004 Apr; 103(7):2668-76. PubMed ID: 14630812
[TBL] [Abstract][Full Text] [Related]
34. MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.
Chen M; Barnfield C; Näslund TI; Fleeton MN; Liljeström P
J Virol; 2005 Mar; 79(5):2964-72. PubMed ID: 15709016
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.
Cheng K; Zhao R; Li Y; Qi Y; Wang Y; Zhang Y; Qin H; Qin Y; Chen L; Li C; Liang J; Li Y; Xu J; Han X; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
Nat Commun; 2021 Apr; 12(1):2041. PubMed ID: 33824314
[TBL] [Abstract][Full Text] [Related]
37. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
38. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.
Schuurhuis DH; van Montfoort N; Ioan-Facsinay A; Jiawan R; Camps M; Nouta J; Melief CJ; Verbeek JS; Ossendorp F
J Immunol; 2006 Apr; 176(8):4573-80. PubMed ID: 16585547
[TBL] [Abstract][Full Text] [Related]
39. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner.
Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK
Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912
[TBL] [Abstract][Full Text] [Related]
40. Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells.
Eguchi M; Sekiya Y; Kikuchi Y; Takaya A; Yamamoto T; Matsui H
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):411-20. PubMed ID: 17573927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
